Related Experiment Video

Updated: May 5, 2026

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

1.3K

A reversible gene-targeting strategy identifies synthetic lethal interactions between MK2 and p53 in the DNA damage

Sandra Morandell1, H Christian Reinhardt, Ian G Cannell

  • 1David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.

Cell Reports
|November 19, 2013
PubMed

Insights

Researchers identified a synthetic lethal interaction between p53 and MAPKAPK2 (MK2) in cancer. Inhibiting MK2 can enhance DNA-damaging chemotherapy effectiveness in p53-deficient tumors, offering new therapeutic strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • Developing effective cancer therapies requires identifying synthetic lethal interactions between tumor mutations and DNA damage response (DDR) pathways.
  • The p38 MAPK/MAPKAP kinase-2 (MK2) pathway is crucial for DDR in p53-deficient cancer cells.
  • Targeting DDR offers a promising strategy for cancer treatment.

Purpose of the Study:

  • To investigate the in vivo relevance of the MK2 pathway in cancer therapy.
  • To identify synthetic lethal interactions involving MK2 in p53-deficient tumors.
  • To explore MK2 as a target for enhancing chemotherapy efficacy.

Main Methods:

  • Developed a gene targeting strategy using Cre-mediated recombination to generate isogenic MK2-proficient and MK2-deficient tumors in vivo.
  • Utilized an autochthonous non-small-cell lung cancer (NSCLC) model.
  • Assessed tumor response to genotoxic treatment (cisplatin).

Main Results:

  • Demonstrated that MK2 confers resistance to cisplatin in p53-deficient NSCLC tumors.
  • Established a synthetic lethality between p53 deficiency and MK2.
  • Showcased the potential of targeting MK2 for cancer therapy.

Conclusions:

  • The p53-MK2 interaction represents a viable synthetic lethal target in cancer.
  • Exploiting the p53-MK2 synthetic lethality can enhance tumor sensitization to DNA-damaging agents.
  • This finding supports the development of novel therapeutic strategies for p53-deficient cancers.

More Related Videos

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

3.4K
A New Toolkit for Evaluating Gene Functions using Conditional Cas9 Stabilization08:20

A New Toolkit for Evaluating Gene Functions using Conditional Cas9 Stabilization

Published on: September 2, 2021

3.5K

Related Concept Videos

In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
14.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
5.7K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
8.5K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
2.4K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
32.1K